The new feature will be available on the Pixel Watch 4 as well.
A team of BioNTech alumni thinks cancer screening has been stuck in the past, and it has raised $25M to do something about it. Bios Life has emerged from stealth with a plan to replace one-off screening with continuous, AI-driven surveillance, and a da…
Apple is in late-stage testing on three Apple Watch models for this autumn, Bloomberg’s Mark Gurman reported: the Series 12 in Wi-Fi and cellular versions, plus the Ultra 4. He has not heard of a new Apple Watch SE planned for 2026. That absence is the…
Hers is testing the new feature with weight loss patients on GLP-1 medications, but plans to expand the service.
The clearest sign of China’s drug-development surge is not a molecule but a monkey. The price of a research primate there has climbed toward 150,000 yuan, roughly $26,000, and it keeps rising. That is a steep jump in a short time. The figure is up from…
NHS England has admitted that a key data-protection document misstated who could see patients’ medical records. It did not disclose the whole arrangement. Staff at Palantir, the US data-analytics firm, can view identifiable patient data inside part of …
The race to build an AI “foundation model of the cell” has a fuel problem. The biological data needed to train one is scarce, messy and inconsistent. Relation Therapeutics thinks the answer is to manufacture that data itself, and GSK is paying up to $1…
Most AI imaging startups build one model per disease. A Cambridge company has raised $20m to build a single model for the whole chest. Then it can spin the rest out of that. Qureight makes AI imaging tools for lung and heart clinical trials. It closed …
Less than a year ago, AlphaFold won Google DeepMind a Nobel Prize. Now DeepMind has taken the team that built it apart. The lab has reassigned most of the original AlphaFold-paper authors over the past year, the Financial Times reported. Nearly a quart…
ICON plc has agreed a multi-year collaboration with Anthropic to put Claude across the clinical trial process. The Dublin company is a contract research organisation, which means pharmaceutical firms pay it to run their trials. It employed roughly 40,2…